Drug Type Degrader-antibody conjugates |
Synonyms |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neuroendocrine Tumors | Discovery | South Korea | 31 May 2024 | |
| Small Cell Lung Cancer | Discovery | South Korea | 21 Nov 2023 |






